Security key
007002108
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, par value $0.0001
- Total 13F shares
- 60,511
- Total 13F value
- $509,503
- Share change
- -51,340,484
- SEC-reported price per share
- $8.42
- Number of holders
- 1
- Value change
- -$48,502,668
- Number of sells
- 53
- Shares outstanding
- 9,599,852
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
1
Top holders
1
ACET full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Adicet Bio, Inc. SEC filings
Adicet Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 007002108
Recent filing periods:
Ownership snapshot
Top reported holders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRANKLIN RESOURCES INC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 6.5%
13D/G row: FRANKLIN RESOURCES INC
Showing 1-6 of 15 holder rows.
Quick read
FRANKLIN RESOURCES INC leads the comparable SEC ownership view at 6.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRANKLIN RESOURCES INC's linked filing trail.
Comparable ownership
Top 5
FRANKLIN RESOURCES INC
6.5%
TANG CAPITAL MANAGEMENT LLC
0.1%
ORBIMED ADVISORS LLC
119%
RA CAPITAL MANAGEMENT, L.P.
79%
GOLDMAN SACHS GROUP INC
39%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC |
13D/G
|
6.5%
|
$5,238,572
626,571 shares
|
$0 | 31 Dec 2025 |
| TANG CAPITAL MANAGEMENT LLC |
13F
13D/G
Company
|
0.1%
from 13D/G
|
$6,662,770
8,223,612 shares
|
— | 30 Sep 2025 |
| ORBIMED ADVISORS LLC |
13F
Company
|
119%
|
$9,274,473
11,447,140 shares
|
— | 30 Sep 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
79%
|
$6,109,718
7,541,000 shares
|
— | 30 Sep 2025 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
39%
|
$3,039,560
3,751,617 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
34%
|
$2,650,743
3,272,522 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
60,511
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
53
Q4 2025 holders
1
Holder diff
-52
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend